When Medicare reduced reimbursements for oncologists in 2003, some physicians started giving their patients more expensive chemotherapy and other cancer treatments—in return for kickbacks from the pharmaceutical companies, a new study has found.
Concerned about the chemicals in traditional household cleaners? A new standard provides customers the information they need to make informed decisions.
Consumer Reports has now stated that nearly 80% of Americans prefer to take a pill for depression when presented with other options including talk therapy. Consumer Reports went on to note that in a survey of 1500 readers, they benefited equally from talk therapy as they did from antidepressant medication.
We’ve received some questions from a couple of our readers recently about some rumors that have been flying around the internet. Here is one:
ANH–USA strongly opposed the recently enacted healthcare bill for a variety of reasons. We stand for the freedom of consumers to choose the type of healthcare they want, and the freedom of practitioners to practice without harassment. The healthcare reform act seriously impinges on both. So after a thorough review of our legal options, which took some time, we have decided to join a lawsuit that has been initiated by a distinguished group of physicians to have the act repealed.
It has become a perennial political argument. Is it wise to involve government in health care? Does the government practicing medicine help people to live longer, live better, or make healthcare more efficient? The Medicare regulations alone, more profuse than those from the IRS, have caused many a physician to say “I wouldn’t choose this […]
An important ruling was recently handed down by the European Court of Justice in April about supplement regulation.
The American Dietetic Association (ADA) sponsored legislation that threatened to give Registered Dieticians a monopoly on nutrition services in Wisconsin. With your help this was defeated.
ANH-International plans legal challenge to the European Union’s attack on herbal medicines.
Next week the title of our newsletter will change, but the focus will remain unchanged.